How many patents does
Sarepta Therapeutics have?
patents
741
families
70
granted
164
applications
577
US
188
EP
98
WO
63
JP
54
CN
27
KR
22
RoW
289
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Sarepta Therapeutics
Top ten assignees appearing on patents
2009 - 2018
| sarepta therapeutics | 471 |
| avi biopharma | 170 |
| serepta therapeutics | 4 |
| isis pharmaceuticals | 4 |
| ercole biotech | 2 |
| ionis pharmaceuticals | 1 |
| sage therapeutics | 1 |
2009
| avi biopharma | 25 |
| isis pharmaceuticals | 1 |
| ercole biotech | 1 |
| sarepta therapeutics | 1 |
2018
| sarepta therapeutics | 119 |
Sarepta Therapeutics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| multiple exon skipping compositions for dmd | 51 | 2008 |
| oligonucleotide analogues targeting human lmna | 35 | 2011 |
| functionally-modified oligonucleotides and subunits thereof | 28 | 2011 |
| oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | 27 | 2010 |
| method of synthesis of morpholino oligomers | 26 | 2007 |
| antisense antiviral compound and method for treating influenza viral infection | 24 | 2009 |
| exon skipping compositions for treating muscular dystrophy | 23 | 2013 |
| boronic acid conjugates of oligonucleotide analogues | 21 | 2012 |
| oligonucleotide analogs having cationic intersubunit linkages | 21 | 2006 |
| antisense antiviral compounds and methods for treating a filovirus infection | 19 | 2010 |